首頁 > 市場調查報告書 > 製藥

再生醫學細胞療法

市場調查報告書

商品編碼

1566170

幹細胞製造市場規模、佔有率、成長分析、按產品、按應用、按最終用戶、按地區 - 產業預測，2024-2031 年

Stem Cell Manufacturing Market Size, Share, Growth Analysis, By Product, By Application, By End User, By Region - Industry Forecast 2024-2031

出版日期: 2024年10月03日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2022年幹細胞製造市場規模預估為125.8億美元，從2023年的137.6億美元成長到2031年的282.3億美元，預測期間（2024-2031年）複合年成長率為9.4%，預計將成長至2022年。

由於慢性病盛行率不斷上升以及對再生醫學的需求不斷增加，全球幹細胞製造市場正在經歷強勁成長。幹細胞療法在治療心血管疾病、神經退化性疾病、癌症等方面顯示出巨大功效，推動了提高製造能力的需求。同時，對幹細胞治療相關研發的大力投資正在進一步支持該市場的擴張。技術創新，包括幹細胞培養技術、反應器和品管系統的進步，大大提高了製造流程的可擴展性和可重複性，使其更具商業性可行性並吸引更多投資。然而，他們也面臨阻礙治療方法開發的障礙，包括有關幹細胞（特別是胚胎幹細胞）使用的倫理和監管問題。遵守嚴格的法規對製造商來說也是一個挑戰，使市場成長更加複雜。此外，由於需要專業基礎設施、熟練勞動力和嚴格的品管措施，製造成本較高，可能會成為進入壁壘，特別是對於小型營業單位和研究機構而言。此外，在幹細胞固有的變異性中確保品質的一致性仍然是一個重大挑戰。隨著製造商努力標準化通訊協定並解決這些技術複雜性，美國幹細胞製造市場預計將在預測期內繼續成長，並將在再生醫學的未來中發揮關鍵作用，相信這一目標將會實現。

市場概況
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲國家地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲 (MEA)
- 海灣合作理事會國家
- 南非
- 其他中東/非洲地區

競爭格局

前5名企業對比
主要企業市場定位（2023年）
主要市場參與者所採取的策略
近期市集活動
主要企業市場佔有率（2023年）

主要企業簡介

Thermo Fisher Scientific, Inc.
Merck KGaA
Lonza Group
Danaher Corporation
Sartorius AG
Becton, Dickinson and Company
Eppendorf SE
Corning Incorporated
Bio-Rad Laboratories, Inc.
Takara Bio Inc.
Fujifilm Holdings Corporation
Getinge AB
Terumo Corporation
Bio-Techne Corporation
Himedia Laboratories Pvt. Ltd.
Stemcell Technologies, Inc.
Miltenyi Biotec GmbH
Promocell
Anterogen Co. Ltd.
Cellgenix GmbH
Pluristem Therapeutics Inc.
Daiichi Sankyo
Organogenesis Holdings Inc.
Vericel Corp.
American Cryostem Corp.

簡介目錄

Product Code: SQMIG35B2172

Stem Cell Manufacturing Market size was valued at USD 12.58 Billion in 2022 and is poised to grow from USD 13.76 Billion in 2023 to USD 28.23 Billion by 2031, at a CAGR of 9.4% during the forecast period (2024-2031).

The global stem cell manufacturing market is witnessing robust growth fueled by the rising incidence of chronic diseases and an increasing demand for regenerative medicine. Stem cell therapies have demonstrated significant efficacy in treating conditions such as cardiovascular diseases, neurodegenerative disorders, and cancer, thereby propelling the need for enhanced manufacturing capabilities. Concurrently, robust investments in research and development initiatives pertaining to stem cell therapies are further bolstering this market expansion. Technological innovations, including advancements in stem cell culture techniques, bioreactors, and quality control systems, have significantly improved the scalability and reproducibility of manufacturing processes, making them more commercially viable and attracting additional investments. However, the market faces hurdles, particularly ethical and regulatory concerns surrounding stem cell use, especially in embryonic cases, which may hinder therapy development. Compliance with stringent regulations also poses challenges for manufacturers, further complicating market growth. Additionally, high manufacturing costs, stemming from the need for specialized infrastructure, skilled labor, and rigorous quality control measures, can create barriers to entry, particularly for smaller entities or research institutions. Furthermore, ensuring consistent quality amid the inherent variability of stem cells remains a significant challenge. As manufacturers strive to standardize protocols and tackle these technical complexities, the U.S. market for stem cell manufacturing is expected to experience sustainable growth in the upcoming forecast period, reinforcing its critical role in the future of regenerative medicine.

Top-down and bottom-up approaches were used to estimate and validate the size of the Stem Cell Manufacturing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Stem Cell Manufacturing Market Segmental Analysis

Global Stem Cell Manufacturing Market is segmented by Product, Application, End User and Region. Based on Product, the market is segmented into Consumables (Culture Media, Other Consumables), Instruments (Bioreactors & Incubators, Cell Sorters, Other Instruments), Stem Cell Lines (Hematopoietic Stem Cells, Mesenchymal Stem Cells, Induced Pluripotent Stem Cells, Embryonic Stem Cells, Neural Stem Cells, Multipotent Adult Progenitor Stem Cells). Based on Application, the market is segmented into Research Applications (Life Science Research, Drug Discovery & Development), Clinical Applications (Allogeneic Stem Cell Therapy, Autologous Stem Cell Therapy), Cell & Tissue Banking Applications. Based on End User, the market is segmented into Pharmaceutical & Biotechnology Companies, Academic Institutes, Research Laboratories, and Contract Research Organizations, Hospitals & Surgical Centers, Cell & Tissue Banks, Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Stem Cell Manufacturing Market

The escalating prevalence of chronic diseases, including cardiovascular disorders, neurological conditions, and various types of cancer, is significantly propelling the global stem cell manufacturing market. As these conditions become increasingly common, the quest for innovative and effective treatment modalities intensifies, positioning stem cells at the forefront of regenerative medicine. Their unique ability to differentiate into various cell types and promote tissue repair presents promising therapeutic avenues for these debilitating health issues. Consequently, the rising demand for advanced stem cell therapies fuels the expansion of manufacturing capabilities, enhancing research and clinical applications that can lead to improved patient outcomes and quality of life.

Restraints in the Stem Cell Manufacturing Market

The stem cell manufacturing market faces significant restraints due to the complex and specialized nature of its processes, which require advanced technology and meticulous quality control measures. Such demands lead to elevated manufacturing costs, heavily influenced by the need for skilled personnel, state-of-the-art infrastructure, and comprehensive quality assurance protocols. These high expenses create substantial financial barriers for market players, ultimately restricting the availability and accessibility of stem cell therapies to a wider population. Consequently, this not only hampers market growth but also limits innovation and investment in the development of new therapeutic options within the industry.

Market Trends of the Stem Cell Manufacturing Market

The Stem Cell Manufacturing market is witnessing a significant trend towards ethical and sustainable sourcing, driven by increasing consumer awareness and regulatory pressures. Companies are increasingly prioritizing alternative sources, such as induced pluripotent stem cells (iPSCs) and mesenchymal stem cells (MSCs), which offer promising avenues for reducing reliance on controversial sources. Investments in research and development are accelerating, focusing on innovative and efficient methods for stem cell derivation and culture that align with ethical standards. This shift not only fosters public trust but also enhances the market's credibility, positioning stakeholders to capitalize on emerging opportunities while ensuring social responsibility.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Key Success Factor
Degree of Competition
Top Investment Pockets
Ecosystem of the Market
Technology Analysis
Supply Chain Analysis
Value Chain Analysis
Pricing Analysis
Patent Analysis
Customer & Buying Criteria Analysis

Stem Cell Manufacturing Market, By Product

Market Overview
Consumables
- Culture Media
- Other Consumables
Instruments
- Bioreactors & Incubators
- Cell Sorters
- Other Instruments
Stem Cell Lines
- Hematopoietic Stem Cells
- Mesenchymal Stem Cells
- Induced Pluripotent Stem Cells
- Embryonic Stem Cells
- Neural Stem Cells
- Multipotent Adult Progenitor Stem Cells

Stem Cell Manufacturing Market, By Application

Market Overview
Research Applications
- Life Science Research
- Drug Discovery & Development
Clinical Applications
- Allogeneic Stem Cell Therapy
- Autologous Stem Cell Therapy
Cell & Tissue Banking Applications

Stem Cell Manufacturing Market, By End User

Market Overview
Pharmaceutical & Biotechnology Companies
Academic Institutes, Research Laboratories, And Contract Research Organizations
Hospitals & Surgical Centers
Cell & Tissue Banks
Other End Users

Stem Cell Manufacturing Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

Thermo Fisher Scientific, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lonza Group
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danaher Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sartorius AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton, Dickinson and Company
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eppendorf SE
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Corning Incorporated
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Takara Bio Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fujifilm Holdings Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Getinge AB
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Terumo Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Techne Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Himedia Laboratories Pvt. Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Stemcell Technologies, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Miltenyi Biotec GmbH
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Promocell
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Anterogen Co. Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cellgenix GmbH
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pluristem Therapeutics Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Daiichi Sankyo
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Organogenesis Holdings Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Vericel Corp.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
American Cryostem Corp.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments